Search by Drug Name or NDC
NDC 10144-0342-04 Inbrija 42 mg/1 Details
Inbrija 42 mg/1
Inbrija is a RESPIRATORY (INHALATION) CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Acorda Therapeutics, Inc.. The primary component is LEVODOPA.
MedlinePlus Drug Summary
Levodopa inhalation is used along with the combination of levodopa and carbidopa (Duopa, Rytary, Sinemet) to treat ''off'' episodes (times of difficulty moving, walking, and speaking that may happen when other medication(s) wear off) in people with Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance). Levodopa inhalation will not work to prevent ''off'' episodes but will help to control symptoms when an ''off'' episode has already begun. Levodopa is in a class of medications called dopamine agonists. Levodopa works by mimicking the action of dopamine, a natural substance in the brain that is lacking in patients with PD.
Related Packages: 10144-0342-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Levodopa Oral Inhalation
Product Information
| NDC | 10144-0342 |
|---|---|
| Product ID | 10144-342_f2a3ac4a-132d-6200-e053-2995a90af649 |
| Associated GPIs | 73200040000160 |
| GCN Sequence Number | 079478 |
| GCN Sequence Number Description | levodopa CAPSULE 42 MG INHALATION |
| HIC3 | H6A |
| HIC3 Description | ANTIPARKINSONISM DRUGS,OTHER |
| GCN | 45975 |
| HICL Sequence Number | 001897 |
| HICL Sequence Number Description | LEVODOPA |
| Brand/Generic | Brand |
| Proprietary Name | Inbrija |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | levodopa |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | RESPIRATORY (INHALATION) |
| Active Ingredient Strength | 42 |
| Active Ingredient Units | mg/1 |
| Substance Name | LEVODOPA |
| Labeler Name | Acorda Therapeutics, Inc. |
| Pharmaceutical Class | Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA209184 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10144-0342-04 (10144034204)
| NDC Package Code | 10144-342-04 |
|---|---|
| Billing NDC | 10144034204 |
| Package | 1 BLISTER PACK in 1 CARTON (10144-342-04) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01) |
| Marketing Start Date | 2019-08-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |